Cystic fibrosis drug Trikafta moving closer to approval

Cystic fibrosis (CF) affects 43-hundred people in Canada, including 130 in Saskatchewan. Most of them don’t have access to any life-changing gene modifier drugs/medications that are available in other countries. Many CF patients are hopeful a drug called Trikafta moves closer to being approved in Canada.

MANY CF PATIENTS ARE REMAINING OPTIMISTIC AS THE DRUG TRIKAFTA INCHES ITS WAY CLOSER TO BE APPROVED IN CANADA.

View original article here Source